HomeREGULATORY
REGULATORY

MHLW Counterfeit Drug Panel Agrees on “Voluntary” Introduction of GDP in Japan
(Nov.14.2017)

MHLW Panel on Counterfeit Drugs on Nov. 10
A health ministry panel on counterfeit drugs on November 10 agreed to introduce Good Distribution Practice (GDP) guidelines in Japan on a voluntary basis, calling on all parties involved in ethical drug distributions to make good faith efforts to observe them ...
(LOG IN FOR FULL STORY)

News Calendar